Vaccine features and key challenges
Key challenges include:
Managing multiple drug containment requirements
Supporting global accessibility and distribution
Ensuring manufacturing excellence
Markets
Stevanato Group has long supported the vaccine value chain with advanced syringe and vial systems for liquid and lyophilized formulations, available in bulk and sterile configurations. Our offering is designed to support high-speed, high-volume production while helping pharmaceutical companies ensure quality, safety, and supply reliability.
In addition, Stevanato Group provides inspection technologies for particle detection, cosmetic defect control, and container integrity testing, including leak detection solutions.
Vaccines have a long history, but new technologies such as mRNA, recombinant, viral vector, and compound vaccines are reshaping requirements for storage, delivery, and production. This makes the selection of primary packaging, inspection technologies, and scalable manufacturing solutions a critical step.
Key challenges include:
Managing multiple drug containment requirements
Supporting global accessibility and distribution
Ensuring manufacturing excellence
Stevanato Group can serve vaccine production processes with comprehensive solutions covering the full pharma value chain.Our unique position in the market enables us to be an integrated provider of primary packaging, machinery, and analytical services.
Discover our solutions designed to support vaccine development and manufacturing, from clinical phases to large-scale production.
Our Technology Excellence Centers (TEC) manages customer requests throughout the design and development process by providing phase-appropriate testing for containers and devices.
A ready-to-use (RTU) platform designed to reduce complexity and increase quality in pharma fill and finish operations